Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers
Not Applicable
Completed
- Conditions
- Lung DiseasesAsthma
Atorvastatin to Treat Pulmonary Sarcoidosis
Phase 2
Completed
- Conditions
- Sarcoidosis, Pulmonary
- Interventions
- Other: Placebo Oral Tablet
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2017-05-22
- Target Recruit Count
- 55
- Registration Number
- NCT00279708
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Pediatric Asthma Controller Trial (PACT)
Phase 3
Completed
- Conditions
- AsthmaLung Diseases
Prevention of Early Asthma in Kids (PEAK)
Not Applicable
Completed
- Conditions
- AsthmaLung Diseases
Blood Cell Collection for Future Use in Individuals With Fanconi Anemia
Not Applicable
Completed
- Conditions
- Fanconi Anemia
- First Posted Date
- 2005-12-30
- Last Posted Date
- 2016-07-12
- Target Recruit Count
- 40
- Registration Number
- NCT00271089
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
Phase 1
Completed
- Conditions
- Pulmonary HypertensionChronic Kidney DiseaseSickle Cell Disease
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2019-12-17
- Target Recruit Count
- 7
- Registration Number
- NCT00270478
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
Phase 1
Completed
- Conditions
- Myelodysplastic Syndrome (MDS)
- First Posted Date
- 2005-12-26
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 9
- Registration Number
- NCT00270452
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Conditioned Placebo Effects and Treatment of Hypertension
Phase 2
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesHypertension
Aerosol Cyclosporine for Prevention of Lung Rejection
Phase 2
Completed
- Conditions
- Lung Diseases
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Phase 2
Completed
- Conditions
- ThrombocytopeniaNeutropeniaImmunosuppresionPancytopenia
- Interventions
- Biological: Anti-thymocyte globulin (rabbit)Biological: Anti-thymocyte globulin (horse)
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2017-06-08
- Target Recruit Count
- 136
- Registration Number
- NCT00260689
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath